Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium thiosulfate to prevent cisplatin-induced ototoxicity in intermediate-risk neuroblastoma
ChiCTR2400082442Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sodium thiosulfate in neuroblastoma (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Hearing impairment - Boston classification and Event-free survival. Started Oct 2022; status: recruiting.
02
Drugs
sodium thiosulfate
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on ChiCTR2400082442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082442.